Unique ID issued by UMIN | UMIN000001705 |
---|---|
Receipt number | R000002053 |
Scientific Title | Short-term antibiotic therapy for acute cholangitis after successful endoscopic biliary drainage |
Date of disclosure of the study information | 2009/02/13 |
Last modified on | 2009/12/21 16:47:35 |
Short-term antibiotic therapy for acute cholangitis after successful endoscopic biliary drainage
Short-term antibiotic therapy for acute cholangitis after successful endoscopic biliary drainage
Short-term antibiotic therapy for acute cholangitis after successful endoscopic biliary drainage
Short-term antibiotic therapy for acute cholangitis after successful endoscopic biliary drainage
Japan |
Acute cholangitis
Hepato-biliary-pancreatic medicine |
Others
NO
To evaluate the efficacy and safety of short-term antibiotic therapy for acute cholangitis after successful biliary drainage
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
recurrence rate of cholangitis 3 days after withdrawal of antibiotic therapy
1)Period until normalization of inflammation markers (WBC and CRP)
2)Incidence of complications (liver abscess and sepsis, etc.) related to
cholangitis
3)Readministration rate of antibiotics
4)medical costs
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Intravenous antibiotics therapy for patients diagnosed with acute cholangitis is started immediately.
When < 37 degrees body temperature is maintained for 24 hrs, administration of antibiotics is stopped.
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients with "moderate" or "severe" acute cholangitis, which is defined by "Tokyo Guidelines for the management of acute cholangitis and cholecystitis" and received biliary drainage within 24 hrs after diagnosis
2)Patients of age >= 20 years
3)Written informed consent is reqired from all patients.
1)Patients with the most severe cholangitis requiring catecholamine administration, mechanical ventilation management, or hemodialysis
2)Patients with acute pancreatitis
3)Patients with other active concomitant infections
4)Patients without adequate drainage due to remaining biliary strictures
5)Patients who have undergone biliary stenting or percutaneous biliary drainage
6)Patients with sclerosing cholangitis
7)Patients with previous choledochojejunostomy
8)Patients with previous heart valve replacement
9)Patients with severe cardiovascular disease
10)Patients receiving maintenance hemodialysis
11)Patients with previous history of antibiotic hypersensitivity
12)Patients receiving chemotherapy
13)Patients receiving steroid or immunosuppressive agent
14)Patients who have received antibiotics within 4 weeks before the pre-observation period
15)Inappropriate patients for entry on this study by the judgement of the investigators
20
1st name | |
Middle name | |
Last name | Takeshi Tsujino |
Faculty of Medicine, University of Tokyo
Department of Gastroenterology
7-3-1, Hongo, Bunkyo-ku, Tokyo
03-3815-5411
1st name | |
Middle name | |
Last name | Hirofumi Kogure |
Faculty of Medicine, University of Tokyo
Department of Gastroenterology
7-3-1, Hongo, Bunkyo-ku, Tokyo
03-3815-5411
Faculty of Medicine, University of Tokyo
None
Self funding
NO
2009 | Year | 02 | Month | 13 | Day |
Unpublished
Completed
2007 | Year | 09 | Month | 13 | Day |
2007 | Year | 12 | Month | 01 | Day |
2009 | Year | 09 | Month | 01 | Day |
2009 | Year | 02 | Month | 13 | Day |
2009 | Year | 12 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002053